NextGen Healthcare Statistics Share Statistics NextGen Healthcare has 67.1M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 67.1M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 54.69M Failed to Deliver (FTD) Shares 37 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 4.99M, so 7.44% of the outstanding
shares have been sold short.
Short Interest 4.99M Short % of Shares Out 7.44% Short % of Float 11.09% Short Ratio (days to cover) 6.58
Valuation Ratios The PE ratio is -435.25 and the forward
PE ratio is null.
NextGen Healthcare's PEG ratio is
1.45.
PE Ratio -435.25 Forward PE n/a PS Ratio 1.77 Forward PS n/a PB Ratio 2.88 P/FCF Ratio 180.61 PEG Ratio 1.45
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for NextGen Healthcare.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.03,
with a Debt / Equity ratio of 0.69.
Current Ratio 2.03 Quick Ratio 1.99 Debt / Equity 0.69 Debt / EBITDA 5.72 Debt / FCF 42.96 Interest Coverage 2.58
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $234.7K Profits Per Employee $-953.65 Employee Count 2,783 Asset Turnover 0.73 Inventory Turnover 47.05
Taxes Income Tax 6.96M Effective Tax Rate 161.66%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0.77, so NextGen Healthcare's
price volatility has been higher than the market average.
Beta 0.77 52-Week Price Change n/a 50-Day Moving Average 23.78 200-Day Moving Average 18.75 Relative Strength Index (RSI) 82.49 Average Volume (20 Days) 1,261,934
Income Statement In the last 12 months, NextGen Healthcare had revenue of 653.17M
and earned -2.65M
in profits. Earnings per share was -0.04.
Revenue 653.17M Gross Profit 311.16M Operating Income 16.24M Net Income -2.65M EBITDA 48.04M EBIT 10.6M Earnings Per Share (EPS) -0.04
Full Income Statement Balance Sheet The company has 98.72M in cash and 274.76M in
debt, giving a net cash position of -176.04M.
Cash & Cash Equivalents 98.72M Total Debt 274.76M Net Cash -176.04M Retained Earnings 127.6M Total Assets 857.75M Working Capital 218.92M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 43.66M
and capital expenditures -37.26M, giving a free cash flow of 6.4M.
Operating Cash Flow 43.66M Capital Expenditures -37.26M Free Cash Flow 6.4M FCF Per Share 0.1
Full Cash Flow Statement Margins Gross margin is 47.64%, with operating and profit margins of 2.49% and -0.41%.
Gross Margin 47.64% Operating Margin 2.49% Pretax Margin 0.66% Profit Margin -0.41% EBITDA Margin 7.36% EBIT Margin 2.49% FCF Margin 0.98%
Dividends & Yields NXGN pays an annual dividend of $0.88,
which amounts to a dividend yield of 4.64%.
Dividend Per Share $0.88 Dividend Yield 4.64% Dividend Growth (YoY) 0% Payout Ratio -972.22% Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for NXGN.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 27, 2011. It was a
forward
split with a ratio of 2:1.
Last Split Date Oct 27, 2011 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 3.61 Piotroski F-Score 2
